Proton-Cotransport of Pravastatin Across Intestinal Brush-Border Membrane
- 1 January 1995
- journal article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 12 (11), 1727-1732
- https://doi.org/10.1023/a:1016269806840
Abstract
Purpose. The purpose of the present study is to clarify the intestinal brush-border transport mechanism of a weak organic acid, pravastatin, an HMG-CoA reductase inhibitor. Methods. The transport of pravastatin was studied by using intestinal brush-border membrane vesicles prepared from rabbit jejunum, and uptake by the membrane vesicles was measured using rapid filtration technique. Results. The initial uptake of [14C]pravastatin was markedly increased with decreases in extravesicular pH and showed a clear overshoot phenomenon in the presence of a proton gradient (pHin/out = 7.5/5.5). A protonophore, carbonylcyanide p-trifluoromethoxyphenylhydrazone, significantly reduced the uptake of [14C]pravastatin. In addition, an ionophore for sodium, potassium and proton, nigericin, stimulated the uptake of [14C]pravastatin in the presence of a potassium gradient ([K + ]in/[K+ ]out = 0/145 mM). On the other hand, neither the imposition of an inwardly directed sodium gradient nor an outwardly directed bicarbonate gradient stimulated the uptake of [14C]pravastatin. In the presence of a proton gradient (pHin/out = 7.5/5.5), the initial uptake of pravastatin was saturable with the apparent Kt of 15.2 ± 3.2 mM and Jmax of 10.6 ± 1.21 nmol/mg protein/10 sec. The uptake of pravastatin was significantly inhibited by monocarboxylic acid compounds such as acetic acid and nicotinic acid in a competitive manner but not by di- or tri-carboxylic acids, or acidic amino acid. Conclusions. It was concluded that a pH-dependent transport of pravastatin across the brush-border membrane occurs by a proton-gradient dependent carrier-mediated mechanism rather than by simple diffusion of its unionized form.Keywords
This publication has 15 references indexed in Scilit:
- pH-Dependent and Carrier-mediated Transport of Salicylic Acid Across Caco-2 CellsJournal of Pharmacy and Pharmacology, 1994
- Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier.1993
- Disposition and metabolism of pravastatin sodium in rats, dogs and monkeysEuropean Journal of Drug Metabolism and Pharmacokinetics, 1992
- Carrier-mediated uptake of pravastatin by rat hepatocytes in primary cultureBiochemical Pharmacology, 1992
- Participation of Monocarboxylic Anion and Bicarbonate Exchange System for the Transport of Acetic Acid and Monocarboxylic Acid Drugs in the Small Intestinal Brush-Border Membrane Vesicles.Journal of Pharmacobio-Dynamics, 1991
- pH-Dependent Intestinal Transport of Monocarboxylic Acids: Carrier-Mediated and H+-Cotransport Mechanism Versus pH-Partition HypothesisJournal of Pharmaceutical Sciences, 1990
- Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Carrier-mediated uptake of nicotinic acid by rat intestinal brush-border membrane vesicles and relation to monocarboxylic acid transport.Journal of Pharmacobio-Dynamics, 1990
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Some Physico-Chemical Factors in Drug ActionJournal of Pharmacy and Pharmacology, 1957